Warrants (Details) |
3 Months Ended |
|---|---|
|
Apr. 30, 2022
$ / shares
shares
| |
| Warrants (Tables) | |
| Warrants Outstanding Shares, Beginning | shares | 4,991,000 |
| Exercised, Shares | shares | (500,000) |
| Granted, Shares | shares | 25,000 |
| Warrants Outstanding Shares, Ending | shares | 4,516,000 |
| Warrants Outstanding Weighted Average Conversion Price, Beginning | $ / shares | $ 2.83 |
| Weighted Average Conversion Price, Exercised | $ / shares | 1.00 |
| Weighted Average Conversion Price, Granted | $ / shares | 9.00 |
| Warrants Outstanding Weighted Average Conversion Price, Ending | $ / shares | $ 3.07 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Change in the weighted average exercise price of options outstanding. No definition available.
|